Sameer Ganapathy

Makara Capital Pte Ltd (Makara Capital) is an Independent Private Equity firm founded in 2005 by Ali Ijaz Ahmad. The firm is headquartered in Singapore.

Integra Holdings Ltd. operates as a holding company. It invests in the pharmaceutical industry. The company was founded in 2012 and is headquartered in Jerusalem, Israel.

Barcode Diagnostics Ltd. is engaged in developing a product that assesses the efficacy of different cancer drugs directly on the tumor within the body to select the optimal personalized treatment for each patient. The company was founded by Ronen Eavri, Annie Sabbah, and Avi Schroeder in February 2017 and is headquartered in Nazareth, Israel.

D Pharm Ltd. provides drug development services.

Glassbeam, Inc. operates as a machine data analytics company. It serves manufactures of products such as servers, storage, networking, software, telecom and medical devices. The company was founded in 2004 by Kumar Malavalli and Puneet Pandit and is headquartered in Santa Clara, CA.

Nekko Capital SGEIC SA is an Independent Venture Capital firm founded in 2015 by Félix Arias Gabasa, Mercè Tell García and Santiago Pi Figueras Valls. Nekko Capital SGEIC SA is headquartered in Barcelona with additional offices in Madrid and London.

VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel.

Ikonz Studios Pvt Ltd. is an Indian technology company that helps IP owners, artists, and other established icons manage and monetize their digital assets. The company is based in Hyderabad, India. The company was founded in 2021 by Prasad Vanga, Rana Daggubati, Abinav Varma Kalidindi. The company has partnerships with world-class metaverses, blockchains, NFT platforms, game studios, and fashion designers to bring all your favorite Indian IP characters into the metaverse. Abinav Varma Kalidindi has been the CEO since 2021.

Makara Strategic Acquisition Corp. operates as a blank check company, which engages in affecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on June 4, 2021, and is headquartered in Princeton, NJ.

Makara Capital Partners Pte. Ltd. is a financial services company based in Singapore, Singapore. The Singaporean company specializes in fund management, structuring, and financing. Ali Ijaz Ahmad has been the CEO of the private company since 2006.

Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools.

CureTech Ltd. operates as a biotechnology company. It develops novel and immune modulating products for the treatment and control of cancer. The company was founded by Michael Schickler in 1995 and is headquartered in Yavne, Israel.

DenX Ltd. is engaged in manufacturing of dental equipment. The firm develops and markets image guided technology for dental training and clinical implementation. The company was founded by Hayka Alon in 1994 and is headquartered in Jerusalem, Israel.

Established in 2000, TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transversal drug delivery technology. Its current proprietary drug-product development programs include ViaDerm-hPTH (1-34), a transversal hPTH (1-34) product to treat osteoporosis, undergoing Phase 2B clinical trials, which is developed in collaboration with Eli Lilly, and two additional peptides currently in Phase 1. TransPharma's drug-product development activities utilize its well-proven RF-MicroChannel Technology. Its RF-MicroChannel technology enables the creation of an array of microscopic pores through the very outer skin surface, allowing the delivery of therapeutic doses of a wide portfolio of drugs, including biologics, Its main area of focus. TransPharma's implementation of the RF-MicroChannel Technology is the ViaDerm delivery system. Intended for home use, the ViaDerm delivery system consists of a reusable, handheld, low-cost device and a disposable patch containing a drug. TransPharma's goal is to develop multiple drug-products through strategic partnerships with leading pharmaceutical companies and through independent product development. They believe that combining partnered and proprietary product development ensures capitalizing of both the promise of its technology and its growing capabilities.

BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel.

Yissum Research Development Co. Ltd. (Yissum Research) is a venture capital subsidiary of The Hebrew University of Jerusalem founded in 1964. The firm is headquartered in Jerusalem, Israel.

BioMAS Ltd. is an Israeli pharmaceutical company that was founded in 2000. The private company is based in Jerusalem, Israel and develops drugs that are based on tellurium.

Fireside Investment Advisory LLP (Fireside Ventures) is a venture capital firm founded in 2015 by Kanwaljit Singh and Vinay Singh. The firm headquartered in Bengaluru, India.